Improving underrepresented patient participation in clinical trials: It matters who makes the request
Editor's Note In this investigative study done by the Boston Medical Center (BMC), patients were shown more likely to agree to participate in clinical studies when approached by research staff of the same race or ethnicity as them. The findings were published in JAMA Ophthalmology on October 19. The study…
Survival rates strong following low-risk cardiac surgery
Editor's Note A new study in the Annals of Thoracic Surgery finds that long-term survival rates are extremely promising for patients who receive low-risk isolated surgical aortic valve replacement (SAVR). The study, titled "Survival Following Surgical Aortic Valve Replacement in Low-Risk Patients: A Contemporary Trial Benchmark," was published on October…
Limiting opioid medication did not negatively impact patients post-surgery
Editor's Note A 5-day limit on opioid pain medication prescriptions in Michigan did not negatively impact patient-reported pain levels or satisfaction, JAMA Network October 13 reports. The study, titled "Changes in surgical opioid prescribing and patient-reported outcomes after implementation of an insurer opioid prescribing limit," was published by JAMA Health…
First nasal vaccine in development for deadly Strep A
Editor's Note A new nasal vaccine in development by Griffith University’s Institute for Glycomics in Australia could provide long-term protection against the deadly bacteria Streptococcus A (Strep A), Griffith University's Griffith News October 5 reports. Strep A causes 700 million human infections each year, and there are more than 500,000…
AI brain implants allow paralyzed man to regain use of arms, hands, fingers
Editor's Note In a first of its kind surgical procedure, doctors have installed artificial intelligence (AI) implants in the brain of a 46-year-old man who was paralyzed from a fall on the ice, CNN September 27 reports. The AI implant formed a "digital bridge"–an idea pioneered by the French neuroscientist…
Benefits seen in phase 3 of Alzheimer's drug trial
Editor's Note Eisai, the Japanese drug maker, said on Tuesday September 27, that its experimental drug for Alzheimer’s disease helped slow cognitive decline to those experiencing early stages of the illness. In the phase 3 clinical trials, the drug, called lecanemab, slowed cognitive decline by 27% after 18 months, the…
Study: Robotic surgery safer than open surgery, less recovery time
Editor's Note In this clinical trial, scientists at University College London and the University of Sheffield found that robot-assisted surgery to remove and rebuild bladder cancer allowed patients to “recover much faster and spend considerably (20%) less time” in the hospital, SciTechDaily June 13 reports. Other findings included 52% less…
UW Medicine conducting national clinical trial on inflatable tubular stent
Editor's Note Cardiologists at the University of Washington School of Medicine (UW Medicine) in Seattle, Washington, are participating in a national clinical trial to test a device designed to control bleeding if a vessel near the heart is inadvertently perforated during a catheter-based procedure, Healthcare Purchasing News May 26 reported.…
Free Daily News
- AHA, FBI release resources to address targeted violence in healthcare
- Task force aims to reduce discarded organs, boost transplants
- 2025 Medicare reimbursement cuts spark concern among physicians
- Trump vs. Harris: Key differences in healthcare proposals for Medicaid, Medicare, private insurance, abortion
- Updated AAMI standard addresses chemical sterilization safety, compliance
- Study: Stool tests show promise in reducing colonoscopies for post-polypectomy colorectal cancer surveillance
- Healthcare employment up in October
- Save the date for OR Manager Conference 2025
- Session: Staff resilience during extended downtime
- Session: Managing difficult conversations—How to respond effectively to your team